* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Dividends declared (per SOCE filings): FY2022 40,882 · FY2023 69,814 · FY2024 16,865 — 3-yr total 127,561
JSC Georgia Pharmacy Group ('GPG') is the pharmacy retail and wholesale/distribution business of Georgia Capital PLC (LSE: CGEO), which owns 100%. In 2024 the former JSC Georgia Healthcare Group was renamed Georgia Pharmacy Group and reorganized — its hospital/healthcare arm was spun into a newly-founded JSC Georgia Healthcare Group (id 405746634) and its medical-insurance arm (Imedi L) into a separate common-control entity — leaving GPG with only pharmacy. It consolidates GEPHA (~97.8%) plus the ABC Pharmalogistics, ABC Pharmacia (Armenia), Azpha (Azerbaijan) and Iverta distribution subsidiaries. (Our data still lists this entity under its pre-2024 name, Georgia Healthcare Group.)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 745,711 | 846,306 | 960,558 | 998,029 | 1,211,769 | 1,204,372 | 823,692 | 861,800 | +2.1% |
| Total COGS | 517,712 | 577,705 | 652,993 | 690,519 | 832,567 | 825,187 | 579,370 | 588,554 | +1.8% |
| Gross Profit | 227,999 | 268,601 | 307,565 | 307,510 | 379,202 | 379,185 | 244,322 | 273,246 | +2.6% |
| Gross Margin | 30.6% | 31.7% | 32.0% | 30.8% | 31.3% | 31.5% | 29.7% | 31.7% | |
| Other Operating Income | 0 | 0 | 0 | 0 | 9,175 | 7,939 | 3 | 4,480 | -21.3% |
| 41,724 | 128,041 | 114,548 | 125,796 | 170,416 | 198,685 | 133,906 | 161,293 | +21.3% | |
| EBITDA | 186,275 | 140,560 | 193,017 | 181,714 | 217,961 | 188,439 | 110,418 | 116,433 | -6.5% |
| EBITDA Margin | 25.0% | 16.6% | 20.1% | 18.2% | 18.0% | 15.6% | 13.4% | 13.5% | |
| Total D&A | 25,704 | 33,883 | 54,972 | 58,167 | 62,381 | 71,198 | 35,137 | 41,911 | +7.2% |
| EBIT / Operating Income | 160,571 | 106,677 | 138,045 | 123,547 | 155,580 | 117,241 | 75,281 | 74,522 | -10.4% |
| Total Interest Income | 3,094 | 1,707 | 2,236 | 8,870 | 8,152 | 8,996 | 9,355 | 2,413 | -3.5% |
| Total Interest Expense | 27,313 | 39,316 | 48,034 | 51,371 | 45,947 | 46,286 | 29,903 | 34,970 | +3.6% |
| 4,506 | 1,069 | 10,484 | 66,400 | 9,589 | 3,972 | 10,898 | 14,527 | +18.2% | |
| Profit Before Tax | 131,846 | 70,137 | 81,763 | 14,646 | 127,374 | 75,979 | 43,835 | 27,438 | -20.1% |
| Total Income Tax | 77 | 616 | 1,586 | 3,025 | 2,786 | 2,326 | 807 | 231 | +17.0% |
| Net Profit / (Loss) | 52,870 | 58,588 | 67,641 | 3,965 | 110,382 | 57,781 | 5,336 | 27,141 | -9.1% |
| Net Margin | 7.1% | 6.9% | 7.0% | 0.4% | 9.1% | 4.8% | 0.6% | 3.1% | |
| Other Comprehensive Income | 4,866 | 0 | 59 | 12 | 13 | 124 | 65 | 0 | nmf |
| Total Comprehensive Income | 48,004 | 58,588 | 67,582 | 3,953 | 110,369 | 57,905 | 5,401 | 27,141 | -7.8% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →